Detalles de la búsqueda
1.
Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B.
J Med Virol
; 95(1): e28139, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089764
2.
The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virus.
Virol J
; 18(1): 237, 2021 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844617
3.
Involvement of the circular RNA/microRNA/glucose-6-phosphate dehydrogenase axis in the pathological mechanism of hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 20(6): 530-534, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34548225
4.
Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase.
Mol Pharm
; 15(8): 3260-3271, 2018 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29944378
5.
Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease.
Cell Physiol Biochem
; 37(5): 1641-58, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26535889
6.
[Epigallocatechin gallate attenuates the expression of regulated upon activation normal T cell expressed and secreted induced by lipopolysaccharide in human retinal endothelial cells].
Sheng Li Xue Bao
; 66(2): 145-50, 2014 Apr 25.
Artículo
en Zh
| MEDLINE | ID: mdl-24777404
7.
Pharmaceutical innovation and advanced biotechnology in the biotech-pharmaceutical industry for antibody-drug conjugate development.
Drug Discov Today
; 29(8): 104057, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38844064
8.
Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9.
Heliyon
; 10(7): e28218, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38560106
9.
[Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 42(5): 511-6, 2013 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-24167131
10.
RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells.
Curr Cancer Drug Targets
; 23(2): 103-117, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36028965
11.
Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B.
Inflamm Res
; 61(9): 997-1004, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22684144
12.
[Atorvastatin inhibits the H2O2-induced apoptosis of human vascular endothelial cells through a down-regulation of cleaved caspase-9/caspase-3].
Zhonghua Yi Xue Za Zhi
; 92(24): 1711-4, 2012 Jun 26.
Artículo
en Zh
| MEDLINE | ID: mdl-22944165
13.
Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase.
Curr Cancer Drug Targets
; 22(4): 312-327, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951367
14.
The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.
Mol Cancer
; 10: 82, 2011 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21749705
15.
Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report.
Exp Dermatol
; 20(2): 119-24, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21255090
16.
Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics.
Mol Pharm
; 8(6): 2310-9, 2011 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22014215
17.
Development of a novel monoclonal antibody to B7-H4: characterization and biological activity.
Eur J Med Res
; 16(7): 295-302, 2011 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21813370
18.
[Serum IL-18 levels in mice with collagen-induced arthritis treated by recombinant adenovirus containing mIL-18BP and mIL-4 fusion gene].
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 40(2): 195-9, 2011 03.
Artículo
en Zh
| MEDLINE | ID: mdl-21488217
19.
Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase.
Ther Adv Med Oncol
; 13: 17588359211006957, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33868463
20.
Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase.
Drug Discov Today
; 26(1): 106-121, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171292